QNRX - Quoin Pharmaceuticals, Ltd.

8.67
0.100   1.153%

Share volume: 13,042
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$8.57
0.10
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
32%
Profitability 35%
Dept financing 43%
Liquidity 21%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-0.80%
1 Month
21.57%
3 Months
-42.39%
6 Months
17.64%
1 Year
2,864.10%
2 Year
634.75%
Key data
Stock price
$8.67
P/E Ratio 
0.00
DAY RANGE
$8.46 - $8.97
EPS 
-$19.98
52 WEEK RANGE
$0.17 - $41.80
52 WEEK CHANGE
$2,864.10
MARKET CAP 
1.522 M
YIELD 
N/A
SHARES OUTSTANDING 
30.203 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
04-09-2025
NEXT EARNINGS DATE
05-08-2025
BETA 
-0.23
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$12,486
AVERAGE 30 VOLUME 
$25,909
Company detail
CEO: Michael Myers
Region: US
Website: quoinpharma.com
Employees: 4
IPO year: 2016
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Quoin Pharmaceuticals, Ltd. focuses on the development of therapeutic products for rare and orphan diseases. It offers QRX003, a topical lotion to treat Netherton Syndrome; QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease.

Recent news